TENX - テナックス・セラピュ―ティックス (Tenax Therapeutics Inc.)

TENXのニュース

   Thinking about buying stock in Tenax Therapeutics, Allena Pharmaceuticals, Trevena, Adaptimmune Therapeutics, or Aurora Cannabis?  2020/06/02 13:31:00 PR Newswire
NEW YORK, June 2, 2020 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for TENX, ALNA, TRVN, ADAP, and ACB. To see how InvestorsObserver's proprietary scoring system rates these stocks, view the InvestorsObserver's PriceWatch Alert by selecting the corresponding link….
   The Daily Biotech Pulse: ASCO Presentations Begin, Altimmune Pops On Insider Buying, Immutep Gets R&D Grant  2020/05/29 11:22:24 Benzinga Feeds
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 28) ADC Therapeutics SA (NYSE: ADCT ) (IPOed May 15) Aerpio Pharmaceuticals Inc (NASDAQ: ARPO )( announced a collaboration study for razuprotafib in COVID-19 treatment) Aileron Therapeutics Inc (NASDAQ: ALRN ) Arca Biopharma Inc (NASDAQ: ABIO ) ( reacted to its planned foray into COVID-19 treatment) argenx SE – ADR (NASDAQ: ARGX ) Bio-Rad Laboratories, Inc. (NYSE: BIO ) BioSpecifics Technologies Corp. (NASDAQ: BSTC ) ChemoCentryx Inc (NASDAQ: CCXI ) GENMAB A/S/S ADR (NASDAQ: GMAB )(announced positive topline Phase 3 data for daratumumab in light-chain amyloidosis) Imara Inc NASDAQ: (IMRA) Liquidia Technologies Inc (NASDAQ: LQDA ) Mersana Therapeutics Inc (NASDAQ: MRSN ) Protagonist Therapeutics Inc (NASDAQ: PTGX ) Qiagen NV (NYSE: QGEN ) Tenax Therapeutics Inc (NASDAQ: TENX ) Turning Point Therapeutics Inc (NASDAQ: TPTX ) Vermillion, Inc. (NASDAQ: VRML ) Down In The Dumps (Biotech Stocks Hitting 52-week Lows May 28) Zafgen Inc (NASDAQ: ZFGN ) Stocks In Focus Karyopharm to Present Positive Selinexor Data In Multiple Myeloma Patients At ASCO Karyopharm Therapeutics Inc (NASDAQ: KPTI ) announced detailed results from the pivotal Phase 3 BOSTON study that evaluated once-weekly selinexor in combination with once-weekly Velcade and low-dose dexamethasone, or SVd, compared to the standard twice-weekly Velcade plus low-dose dexamethasone, or Vd, in second-line to fourth-line setting in multiple myeloma patients.
   Tenax Therapeutics Announces Last Patient Completes Final Visit in its Phase 2 “HELP Study” of Levosimendan for Pulmonary Hypertension and Heart Failure with Preserved Ejection Fraction  2020/04/09 12:30:00 Business Wire
MORRISVILLE, N.C.--(BUSINESS WIRE)--Tenax Therapeutics, Inc. (NASDAQ: TENX) announces last visit completed in Phase 2 levosimendan trial in PH-HFpEF. Top-line data readout in Q2.
   Tenax Therapeutics Announces $2.75 Million Registered Direct Offering Priced At-the-Market  2020/03/12 12:00:00 Business Wire
MORRISVILLE, N.C.--(BUSINESS WIRE)--Tenax Therapeutics, Inc. (NASDAQ: TENX) Enters Agreement For $2.75 Million in Registered Direct Offering
   Tenax Announces the Addition of Mayo Clinic Expert, Dr. Barry Borlaug, to Scientific Advisory Board  2020/02/21 13:30:00 Business Wire
MORRISVILLE, N.C.--(BUSINESS WIRE)--Tenax Therapeutics, Inc. (NASDAQ: TENX) adds Dr. Barry Borlaug of Mayo Clinic to scientific advisory board for Phase 2 levosimendan trial in PH-HFpEF
   Tenax Announces the Addition of Mayo Clinic Expert, Dr. Barry Borlaug, to Scientific Advisory Board  2020/02/21 13:30:00 Business Wire
MORRISVILLE, N.C.--(BUSINESS WIRE)--Tenax Therapeutics, Inc. (NASDAQ: TENX) adds Dr. Barry Borlaug of Mayo Clinic to scientific advisory board for Phase 2 levosimendan trial in PH-HFpEF
   Tenax Therapeutics Provides Update on Phase 2 Pulmonary Hypertension Clinical Trial  2019/10/31 12:00:00 ACI Information Group
Tenax Therapeutics, Inc. (TENX), a specialty pharmaceutical company focused on identifying, developing and commercializing products that address cardiovascular and pulmonary diseases with high unmet medical need, today provided an update on its on-going clinical trial of levosimendan. Tenax is conducting
   Automakers, Macau Names And CinemaCon Action (Stocks To Watch Podcast)  2019/03/31 11:35:56 Seeking Alpha
   AZN and SGH among premarket losers  2019/03/29 13:18:41 Seeking Alpha
   Tenax Therapeutics and Fibrocell Science among healthcare gainers; Proteon Therapeutics lead the losers  2019/03/28 15:07:44 Seeking Alpha
   Tenax Therapeutics Provides Update on Phase 2 Pulmonary Hypertension Clinical Trial  2019/10/31 12:00:00 ACI Information Group
Tenax Therapeutics, Inc. (TENX), a specialty pharmaceutical company focused on identifying, developing and commercializing products that address cardiovascular and pulmonary diseases with high unmet medical need, today provided an update on its on-going clinical trial of levosimendan. Tenax is conducting
   Automakers, Macau Names And CinemaCon Action (Stocks To Watch Podcast)  2019/03/31 11:35:56 Seeking Alpha
   AZN and SGH among premarket losers  2019/03/29 13:18:41 Seeking Alpha
   Tenax Therapeutics and Fibrocell Science among healthcare gainers; Proteon Therapeutics lead the losers  2019/03/28 15:07:44 Seeking Alpha
   Healthcare names top midday movers  2019/03/18 16:46:44 Seeking Alpha

calendar